CorWave
CorWave develops blood pumps based on a unique and patented wave membrane pumping technology. The membrane is the result of more than twenty years of research and development, and is capable of mimicking the native heart. This disruptive technology radically differentiates CorWave products from commercially-available rotary pump LVADs.
Sector
Medical Devices
Strategies
MD Start & Capital
Status
Live
Website
www.corwave.com
Antoine Papiernik
Chairman & Managing Partner, Sofinnova Partners
Anne Osdoit
Partner, Sofinnova Partners - MD Start Strategy
Related News
CorWave announces successful completion of 6-month chronic in vivo study, paving the way for clinical trial initiation
CorWave announces the appointment of Dawn Sadlowski-Buisserez as Vice President of Operations to support the ramp-up of production
CorWave announces the appointment of Fairuz Hasni as Vice President Human Resources
CorWave announces the Grand opening of its manufacturing facility on the banks of the Seine, next to Paris
CorWave announces the appointment of Magalie Durrèche as Chief Financial Officer
SofinnovaCapital
The Sofinnova Capital Strategy is our flagship fund, investing as founding or lead investor in early-stage biopharma and medtech start-ups developing groundbreaking therapeutic technologies.
SofinnovaMD Start
The Sofinnova MD Start Strategy is our in-house medtech accelerator focused on creating and launching early-stage medtech companies through hands-on company building.
SofinnovaCrossover
The Sofinnova Crossover Strategy invests in growth-stage biotech and medtech companies that have clinically validated their technologies and are preparing for commercialization.
SofinnovaIndustrial Biotech
Our Industrial Biotech Strategy invests in early-stage sustainable companies across the agriculture, chemicals, food and materials sectors.
SofinnovaTelethon
The Sofinnova Telethon Strategy makes early-stage investments in leading Italian science for the benefit of patients around the world.
SofinnovaDigital Medicine
Our Digital Medicine Strategy backs early-stage techbio and healthtech start-ups at the intersection of biology, data, and computation.
SofinnovaBiovelocita
The Sofinnova Biovelocita Strategy is our biotech accelerator, partnering with leading research organizations to create and build European biotech start-ups.